WednesdayApr 30, 2025 3:39 pm

QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Engages IBN for Corporate Communications Expertise 

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) is a junior resource company focused on monetizing high-grade mineral assets in British Columbia. The company leverages a unique dual-pronged operational strategy combining solid revenues from its wholly owned, state-of-the-art gold and silver mill with the long-term upside of 100%-owned copper, silver, and gold exploration projects. This approach allows the company to fund ongoing development while minimizing equity dilution.  Nicola Mining has selected IBN, a multifaceted financial news and publishing company serving private and public entities, to spearhead its corporate communications efforts. As part of the client-partner relationship, IBN will generate greater awareness for…

Continue Reading

WednesdayApr 30, 2025 9:48 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2024 Milestones and 2025 Commercialization Goals 

Nutriband (NASDAQ: NTRB) has released a shareholder letter from CEO Gareth Sheridan outlining key achievements in 2024 and plans for 2025, centered on advancing its AVERSA™ abuse-deterrent transdermal technology. The company is transitioning from feasibility to commercial development of AVERSA Fentanyl in partnership with Kindeva Drug Delivery, targeting a pivotal Human Abuse Liability clinical trial and NDA filing. AVERSA Fentanyl and AVERSA Buprenorphine could reach peak annual sales of up to $200 million and $130 million respectively. Nutriband also expanded its global patent portfolio to 46 countries and raised $8.4 million in a non-brokered placement. The company expects continued revenue…

Continue Reading

WednesdayApr 30, 2025 9:20 am

QualityStocksNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) and UAV Corp (OTC: UMAV) Appoints New CEO, Launches BioSentry Division for Real-Time Biohazard Detection

Fifty 1 Labs (OTC: FITY), a leader in technology and wellness innovation, has appointed Michael Lawson as CEO and Chairman while launching its new BioSentry Division focused on advanced biohazard detection. The division will develop real-time sensor systems using PCR, spectrometry and AI-driven analytics to detect biological, chemical and environmental threats, with applications spanning defense, public health, and industrial safety. The company also announced a strategic partnership with UAV Corp (OTC: UMAV) to integrate the sensors with UAVs and plans to issue a UMAV share dividend to FITY shareholders. Meanwhile, Fifty 1 Labs has opted not to proceed with the…

Continue Reading

WednesdayApr 30, 2025 9:10 am

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) CEO Spotlights Waterberg Project on MiningNewsWire Podcast

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is featured in the latest episode of The MiningNewsWire Podcast, where Co-Founder, Director, President and CEO Frank R. Hallam discusses the company’s flagship Waterberg Project in South Africa. Hallam highlights how the deposit—discovered in 2011—stands apart with its shallow depth and exceptional thickness, enabling safer, more cost-efficient, and highly mechanized mining. Unlike traditional South African platinum operations that rely on deep, labor-intensive shafts, Waterberg allows for decline access and heavy machinery. Hallam also shares insights on Lion Battery Technologies, the company's joint venture exploring platinum and palladium applications in lithium batteries, as…

Continue Reading

WednesdayApr 30, 2025 9:00 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Launches Next Phase of Drilling at Iska Iska Silver-Tin Project

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), advancing its Iska Iska silver-tin polymetallic project in southwestern Bolivia, will soon begin a 4,300-meter, eight-hole diamond drilling program targeting the Santa Barbara starter pit area. The campaign is designed to upgrade and expand high-grade tin and silver mineralization, with holes spaced at 50 meters to confirm continuity. CEO Tom Larsen said prior drilling extended mineralization and revealed new targets, contributing to a significantly expanded footprint. The upcoming 2025 phase 1 campaign will further assess the zone's resource potential to support an updated PEA, with ongoing metallurgical studies showing promising results. To…

Continue Reading

TuesdayApr 29, 2025 1:45 pm

QualityStocksNewsBreaks – Better Choice Company, Inc. (NYSE American: BTTR) Completes Merger with SRx Health, Will Rebrand as SRx Health Solutions Inc.

Better Choice Company (NYSE American: BTTR) announced the closing of its business combination with SRx Health Solutions, Inc., along with an $8.8 million private placement involving 4,036,697 shares of common stock and pre-funded warrants priced at $2.18 per share. As part of the merger, Better Choice will issue 28.6 million shares and rebrand as “SRx Health Solutions Inc.” with a new ticker symbol, “SRXH,” effective Apr. 30, 2025. The combined company aims to become a global health and wellness leader focused on solutions for pets, people and families. To view the full press release, visit https://ibn.fm/OWpWX About Better Choice Company…

Continue Reading

TuesdayApr 29, 2025 12:31 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early-stage cutaneous T-cell lymphoma (“CTCL”). Building on the success of a prior phase 3 trial, HyBryte(TM)—which uses synthetic hypericin activated by safe visible light—offers a potentially game-changing approach by providing a noninvasive, well-tolerated alternative that targets malignant T-cells with precision. With patient enrollment underway and interim analysis expected in early 2026, the study is designed to potentially meet the stringent requirements of regulatory agencies in order to strengthen the case for HyBryte(TM) as a commercially available…

Continue Reading

TuesdayApr 29, 2025 11:22 am

QualityStocksNewsBreaks – Adageis Is Reshaping Patient Care Through Smart Tech

Adageis is revolutionizing healthcare with its flexible, AI-centric software solutions and ProActive Care Platform, built to eliminate administrative burdens and enable providers to focus on patients. With simplicity core to its design, the platform empowers healthcare organizations by identifying missed revenue opportunities from insurers and guiding providers to secure rightful payments. Using predictive analytics through its Patented Risk Engine (“PRE”), Adageis enhances steady cash flow by forecasting incentive payments and factoring receivables. The platform seamlessly integrates with over 90 electronic health record systems, minimizing disruption and easing the shift to value-based care. As the healthcare sector continues in this trend, Adageis…

Continue Reading

TuesdayApr 29, 2025 10:46 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands International Reach with Juve Stabia Matches on Destination Calcio TV 

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B squad, S.S. Juve Stabia, will have its next two fixtures streamed live and free in the United States, Canada and United Kingdom via Destination Calcio TV. The matches—against Catanzaro on May 1 and Brescia on May 4—will feature full English commentary and be accessible through the Destination Calcio app and website. Brera Holdings emphasized that expanding Juve Stabia’s global presence aligns with its multi-club ownership strategy and the growing internationalization of football media rights.  To view the full press release, visit https://ibn.fm/KahxW  About Brera Holdings PLC  Brera Holdings PLC is…

Continue Reading

TuesdayApr 29, 2025 9:40 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Technology

HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.4% diagnostic agreement with standard 12-lead ECGs for arrhythmia assessment. Results were presented by Dr. Thomas Deering of Piedmont Heart Institute during the Heart Rhythm Society’s annual conference. HeartBeam’s 3D ECG technology, designed to fit into a credit card-sized device, aims to bring hospital-grade cardiac insights to patients anywhere, with commercialization planned following anticipated FDA clearance. To view the full press release, visit https://ibn.fm/ABvdX About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered